96 related articles for article (PubMed ID: 30032028)
1. The role of lipooligosaccharide in the biological activity of Moraxella bovis strains Epp63, Mb25 and L183/2, and isolation of capsular polysaccharide from L183/2.
Singh S; Grice ID; Peak IR; Frost T; Yue G; Wilson JC
Carbohydr Res; 2018 Sep; 467():1-7. PubMed ID: 30032028
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of the structure of the oligosaccharide from wild type Moraxella bovis Epp63 lipooligosaccharide.
De Castro C; Grice ID; Daal TM; Peak IR; Molinaro A; Wilson JC
Carbohydr Res; 2014 Mar; 388():81-6. PubMed ID: 24632213
[TBL] [Abstract][Full Text] [Related]
3. Identification of a capsular polysaccharide from Moraxella bovis.
Wilson JC; Hitchen PG; Frank M; Peak IR; Collins PM; Morris HR; Dell A; Grice ID
Carbohydr Res; 2005 Mar; 340(4):765-9. PubMed ID: 15721351
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterisation of a biosynthetic locus for Moraxella bovis lipo-oligosaccharide.
Faglin I; Grice ID; Ratnayake SRAME; Daal TM; Singh S; Wilson JC; Peak IR
Carbohydr Res; 2016 Feb; 421():9-16. PubMed ID: 26774874
[TBL] [Abstract][Full Text] [Related]
5. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
McConnel CS; Shum L; Gleeson BL; House JK
Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
[TBL] [Abstract][Full Text] [Related]
6. Q pili enhance the attachment of Moraxella bovis to bovine corneas in vitro.
Ruehl WW; Marrs C; Beard MK; Shokooki V; Hinojoza JR; Banks S; Bieber D; Mattick JS
Mol Microbiol; 1993 Jan; 7(2):285-8. PubMed ID: 8095318
[TBL] [Abstract][Full Text] [Related]
7. Structural characterisation of the oligosaccharide from Moraxella bovoculi type strain 237 (ATCC BAA-1259) lipooligosaccharide.
Grice ID; Peak IR; Dawood WA; King RM; Ravikumaran KS; Speciale I; Molinaro A; de Castro C; Wilson JC
Carbohydr Res; 2021 May; 503():108293. PubMed ID: 33839496
[TBL] [Abstract][Full Text] [Related]
8. Interesting sequence differences between the pilin gene inversion regions of Moraxella lacunata ATCC 17956 and Moraxella bovis Epp63.
Rozsa FW; Marrs CF
J Bacteriol; 1991 Jul; 173(13):4000-6. PubMed ID: 2061282
[TBL] [Abstract][Full Text] [Related]
9. Moraxella ovis and Moraxella bovoculi lipooligosaccharide biosynthesis genes, and structural characterisation of oligosaccharide from M. ovis 354T.
Ravikumaran KS; King RM; Notaro A; Molinaro A; de Castro C; Wilson JC; Grice ID; Peak IR
Carbohydr Res; 2024 Feb; 536():109043. PubMed ID: 38281396
[TBL] [Abstract][Full Text] [Related]
10. Infection rates, disease frequency, pilin gene rearrangement, and pilin expression in calves inoculated with Moraxella bovis pilin-specific isogenic variants.
Ruehl WW; Marrs CF; George L; Banks SJ; Schoolnik GK
Am J Vet Res; 1993 Feb; 54(2):248-53. PubMed ID: 8094276
[TBL] [Abstract][Full Text] [Related]
11. Complete Genome Sequence of Moraxella bovis Strain Epp-63 (300), an Etiologic Agent of Infectious Bovine Keratoconjunctivitis.
Loy JD; Dickey AM; Clawson ML
Microbiol Resour Announc; 2018 Aug; 7(8):. PubMed ID: 30533917
[TBL] [Abstract][Full Text] [Related]
12. Antigenic relationships of Moraxella bovis isolates recovered from outbreaks of infectious bovine keratoconjunctivitis in Argentina, Brazil, and Uruguay between 1983 and 2000.
Conceição FR; Paolicchi F; Cobo AL; Gil-Turnes C
Can J Vet Res; 2003 Oct; 67(4):315-8. PubMed ID: 14620871
[TBL] [Abstract][Full Text] [Related]
13. Antigenic characterization of Moraxella bovis, Moraxella bovoculi and Moraxella ovis strains with potential use in vaccines.
Kowalski AP; Maboni G; Gressler LT; Espíndola JP; Balzan C; Tasca C; Guizzo JA; Conceição FR; Frandoloso R; de Vargas AC
Vet Microbiol; 2017 Oct; 210():56-63. PubMed ID: 29103697
[TBL] [Abstract][Full Text] [Related]
14. Molecular and phenotypic analysis of Moraxella spp. associated with infectious bovine keratoconjunctivitis in Uruguay.
Sosa V; Zunino P
Vet J; 2012 Aug; 193(2):595-7. PubMed ID: 22342890
[TBL] [Abstract][Full Text] [Related]
15. Bovine infectious keratoconjunctivitis: serological aspects of Moraxella bovis infection.
Pugh GW; Hughes DE; McDonald TJ
Can J Comp Med; 1971 Apr; 35(2):161-6. PubMed ID: 4253466
[TBL] [Abstract][Full Text] [Related]
16. Role of different moieties from the lipooligosaccharide molecule in biological activities of the Moraxella catarrhalis outer membrane.
Peng D; Hu WG; Choudhury BP; Muszyński A; Carlson RW; Gu XX
FEBS J; 2007 Oct; 274(20):5350-9. PubMed ID: 17892485
[TBL] [Abstract][Full Text] [Related]
17. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
Angelos JA; Bonifacio RG; Ball LM; Hess JF
Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
[TBL] [Abstract][Full Text] [Related]
18. Partial characterization of a Moraxella bovis cytolysin.
Gray JT; Fedorka-Cray PJ; Rogers DG
Vet Microbiol; 1995 Feb; 43(2-3):183-96. PubMed ID: 7740757
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
Angelos JA; Gohary KG; Ball LM; Hess JF
Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
[TBL] [Abstract][Full Text] [Related]
20. Identification of bovine carriers of Moraxella bovis by comparative cultural examinations of ocular and nasal secretions.
Pugh GW; McDonald TJ
Am J Vet Res; 1986 Nov; 47(11):2343-5. PubMed ID: 3789493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
